Louisiana State Employees Retirement System Invests $968,000 in Sotera Health Company $SHC

Louisiana State Employees Retirement System purchased a new stake in Sotera Health Company (NASDAQ:SHC) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 67,500 shares of the company’s stock, valued at approximately $968,000.

Other large investors have also recently added to or reduced their stakes in the company. OP Asset Management Ltd acquired a new stake in shares of Sotera Health during the first quarter worth approximately $1,668,000. SG Americas Securities LLC grew its position in Sotera Health by 6,382.6% during the 1st quarter. SG Americas Securities LLC now owns 879,489 shares of the company’s stock worth $12,612,000 after acquiring an additional 865,922 shares during the last quarter. Hsbc Holdings PLC bought a new stake in Sotera Health during the 4th quarter worth approximately $833,000. Corient Private Wealth LLC increased its holdings in Sotera Health by 217.4% during the 4th quarter. Corient Private Wealth LLC now owns 44,342 shares of the company’s stock valued at $773,000 after purchasing an additional 30,373 shares in the last quarter. Finally, Pacer Advisors Inc. increased its holdings in Sotera Health by 38.8% during the 4th quarter. Pacer Advisors Inc. now owns 32,173 shares of the company’s stock valued at $568,000 after purchasing an additional 8,993 shares in the last quarter. 91.03% of the stock is owned by institutional investors.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $17.93 on Monday. The company has a 50 day moving average price of $15.97 and a two-hundred day moving average price of $16.35. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The company has a market capitalization of $5.11 billion, a PE ratio of 43.73 and a beta of 1.76. Sotera Health Company has a 52 week low of $10.94 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same period in the previous year, the company posted $0.14 earnings per share. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts forecast that Sotera Health Company will post 0.88 earnings per share for the current year.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.36% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on SHC. Weiss Ratings lowered Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Piper Sandler restated an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. UBS Group set a $19.00 price target on Sotera Health in a report on Wednesday, June 24th. Finally, The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.